Cite
HARVARD Citation
Olshansky, B. et al. (n.d.). Cardiovascular benefits outweigh risks in patients with atrial fibrillation in REDUCE-IT (Reduction of Cardiovascular Events with Icosapent Ethyl-Intervention Trial). European heart journal. p. . [Online].